Xylem Inc. $XYL Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 11.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,208,530 shares of the industrial products company’s stock after selling 157,587 shares during the quarter. Bank of New York Mellon Corp’s holdings in Xylem were worth $164,578,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in XYL. AQR Capital Management LLC boosted its position in Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after acquiring an additional 3,900 shares during the period. NewEdge Advisors LLC boosted its position in Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after acquiring an additional 132 shares during the period. Empowered Funds LLC boosted its position in Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after acquiring an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Xylem by 97.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock worth $1,442,000 after acquiring an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its position in Xylem by 114.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after acquiring an additional 635 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Down 0.3%

Shares of NYSE XYL opened at $109.84 on Friday. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company has a market cap of $26.11 billion, a price-to-earnings ratio of 27.32, a P/E/G ratio of 1.57 and a beta of 1.04. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The business has a fifty day simple moving average of $116.75 and a 200-day simple moving average of $128.41.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The firm had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Sell-side analysts predict that Xylem Inc. will post 5.51 EPS for the current year.

Xylem declared that its Board of Directors has authorized a stock repurchase program on Wednesday, February 25th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the industrial products company to repurchase up to 4.8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Insider Buying and Selling at Xylem

In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the transaction, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

XYL has been the subject of a number of analyst reports. TD Cowen reiterated a “hold” rating on shares of Xylem in a research report on Monday, February 23rd. Barclays reduced their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Stifel Nicolaus reduced their price target on Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. UBS Group boosted their price target on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Finally, The Goldman Sachs Group set a $158.00 price target on Xylem in a research report on Wednesday, February 11th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average target price of $152.77.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.